To compare the structural outcome at 9 months of eyes treated with intravitreal injection of bevacizumab with fellow eyes treated with conventional laser photoablation in zone I type 1 retinopathy of prematurity (ROP).
Lepore, D., Quinn, G., Molle, F., Baldascino, A., Orazi, L., Sammartino Sinicalco, M., Purcaro, V., Giannantonio, C., Papacci, P., Romagnoli, C., Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings, <<OPHTHALMOLOGY>>, 2014; 121 (11): 2212-2219. [doi:10.1016/j.ophtha.2014.05.015] [http://hdl.handle.net/10807/64297]
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings
Lepore, Domenico;Molle, Fernando;Baldascino, Antonio;Orazi, Lorenzo;Sammartino Sinicalco, Maria;Purcaro, Velia;Giannantonio, Carmen;Papacci, Patrizia;Romagnoli, Costantino
2014
Abstract
To compare the structural outcome at 9 months of eyes treated with intravitreal injection of bevacizumab with fellow eyes treated with conventional laser photoablation in zone I type 1 retinopathy of prematurity (ROP).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
